Global and Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2026

Publisher Name :
Date: 15-Oct-2020
No. of pages: 142
Inquire Before Buying

Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into

Analgesic & pain relievers

Dermatological products

Cough, cold, and flu products

Vitamin supplements

Mineral Supplements

Ophthalmic Products

Segment by Application, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into

Pharmacies

Grocery Stores

Vitamin

Health Food Stores

Online Pharmacies

Regional and Country-level Analysis

The Over the Counter (OTC) Drugs & Dietary Supplements market is analysed and market size information is provided by regions (countries).

The key regions covered in the Over the Counter (OTC) Drugs & Dietary Supplements market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Over the Counter (OTC) Drugs & Dietary Supplements Market Share Analysis

Over the Counter (OTC) Drugs & Dietary Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over the Counter (OTC) Drugs & Dietary Supplements business, the date to enter into the Over the Counter (OTC) Drugs & Dietary Supplements market, Over the Counter (OTC) Drugs & Dietary Supplements product introduction, recent developments, etc.

The major vendors covered:

Pfizer Inc.

Novartis International AG

Roche Holding AG

Merck & Co., Inc.

Sanofi S.A

Johnson & Johnson

Gilead Sciences

GlaxoSmithKline plc.

Bayer Healthcare AG

AstraZeneca plc.

Alacer Corp.

Alcon Inc.

Alfresa Pharma Corporation

Alkalon A/S

Alliance Healthcare

Allergan, Plc.

Reckitt Benckiser Plc.

Bausch & Lomb

AbbVie Inc.

The Colgate-Palmolive Company

Global and Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
1.2 Market Segments
1.3 Key Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type
1.4.2 Analgesic & pain relievers
1.4.3 Dermatological products
1.4.4 Cough, cold, and flu products
1.4.5 Vitamin supplements
1.4.6 Mineral Supplements
1.4.7 Ophthalmic Products
1.5 Market by Application
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application
1.5.2 Pharmacies
1.5.3 Grocery Stores
1.5.4 Vitamin
1.5.5 Health Food Stores
1.5.6 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, Estimates and Forecasts
2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2015-2026
2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Historical Market Size by Region (2015-2020)
2.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Region (2021-2026)
2.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Region (2021-2026)
3 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitor Landscape by Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
3.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers (2015-2020)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue
3.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020)
3.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
3.2.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Base Distribution, Product Types
3.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
3.4.3 Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2015-2020)
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020)
4.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Type (2021-2026)
4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2015-2020)
5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020)
5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020)
5.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Application (2021-2026)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
6.1.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales YoY Growth 2015-2026
6.1.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth 2015-2026
6.1.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Share in Global Market 2015-2026
6.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Players (International and Local Players)
6.2.1 Japan Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Sales (2015-2020)
6.2.2 Japan Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2015-2020)
6.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Type (2015-2020)
6.3.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
6.3.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2015-2020)
6.3.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2015-2020)
6.4 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
6.4.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
6.4.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Type (2021-2026)
6.5 Japan Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Application (2015-2020)
6.5.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
6.5.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2015-2020)
6.5.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
6.6 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
6.6.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
6.6.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
7 North America
7.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
7.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
7.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020)
7.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
8.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
8.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
8.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
9.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
9.2.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020)
9.2.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
10.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
10.2.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
10.2.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
11.2.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
11.2.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Corporation Information
12.1.2 Pfizer Inc. Description and Business Overview
12.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Novartis International AG
12.2.1 Novartis International AG Corporation Information
12.2.2 Novartis International AG Description and Business Overview
12.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.2.5 Novartis International AG Recent Development
12.3 Roche Holding AG
12.3.1 Roche Holding AG Corporation Information
12.3.2 Roche Holding AG Description and Business Overview
12.3.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.3.5 Roche Holding AG Recent Development
12.4 Merck & Co., Inc.
12.4.1 Merck & Co., Inc. Corporation Information
12.4.2 Merck & Co., Inc. Description and Business Overview
12.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.4.5 Merck & Co., Inc. Recent Development
12.5 Sanofi S.A
12.5.1 Sanofi S.A Corporation Information
12.5.2 Sanofi S.A Description and Business Overview
12.5.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.5.5 Sanofi S.A Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Gilead Sciences
12.7.1 Gilead Sciences Corporation Information
12.7.2 Gilead Sciences Description and Business Overview
12.7.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.7.5 Gilead Sciences Recent Development
12.8 GlaxoSmithKline plc.
12.8.1 GlaxoSmithKline plc. Corporation Information
12.8.2 GlaxoSmithKline plc. Description and Business Overview
12.8.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.8.5 GlaxoSmithKline plc. Recent Development
12.9 Bayer Healthcare AG
12.9.1 Bayer Healthcare AG Corporation Information
12.9.2 Bayer Healthcare AG Description and Business Overview
12.9.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.9.5 Bayer Healthcare AG Recent Development
12.10 AstraZeneca plc.
12.10.1 AstraZeneca plc. Corporation Information
12.10.2 AstraZeneca plc. Description and Business Overview
12.10.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.10.5 AstraZeneca plc. Recent Development
12.11 Pfizer Inc.
12.11.1 Pfizer Inc. Corporation Information
12.11.2 Pfizer Inc. Description and Business Overview
12.11.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.11.5 Pfizer Inc. Recent Development
12.12 Alcon Inc.
12.12.1 Alcon Inc. Corporation Information
12.12.2 Alcon Inc. Description and Business Overview
12.12.3 Alcon Inc. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Alcon Inc. Products Offered
12.12.5 Alcon Inc. Recent Development
12.13 Alfresa Pharma Corporation
12.13.1 Alfresa Pharma Corporation Corporation Information
12.13.2 Alfresa Pharma Corporation Description and Business Overview
12.13.3 Alfresa Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Alfresa Pharma Corporation Products Offered
12.13.5 Alfresa Pharma Corporation Recent Development
12.14 Alkalon A/S
12.14.1 Alkalon A/S Corporation Information
12.14.2 Alkalon A/S Description and Business Overview
12.14.3 Alkalon A/S Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Alkalon A/S Products Offered
12.14.5 Alkalon A/S Recent Development
12.15 Alliance Healthcare
12.15.1 Alliance Healthcare Corporation Information
12.15.2 Alliance Healthcare Description and Business Overview
12.15.3 Alliance Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Alliance Healthcare Products Offered
12.15.5 Alliance Healthcare Recent Development
12.16 Allergan, Plc.
12.16.1 Allergan, Plc. Corporation Information
12.16.2 Allergan, Plc. Description and Business Overview
12.16.3 Allergan, Plc. Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Allergan, Plc. Products Offered
12.16.5 Allergan, Plc. Recent Development
12.17 Reckitt Benckiser Plc.
12.17.1 Reckitt Benckiser Plc. Corporation Information
12.17.2 Reckitt Benckiser Plc. Description and Business Overview
12.17.3 Reckitt Benckiser Plc. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Reckitt Benckiser Plc. Products Offered
12.17.5 Reckitt Benckiser Plc. Recent Development
12.18 Bausch & Lomb
12.18.1 Bausch & Lomb Corporation Information
12.18.2 Bausch & Lomb Description and Business Overview
12.18.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Bausch & Lomb Products Offered
12.18.5 Bausch & Lomb Recent Development
12.19 AbbVie Inc.
12.19.1 AbbVie Inc. Corporation Information
12.19.2 AbbVie Inc. Description and Business Overview
12.19.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
12.19.4 AbbVie Inc. Products Offered
12.19.5 AbbVie Inc. Recent Development
12.20 The Colgate-Palmolive Company
12.20.1 The Colgate-Palmolive Company Corporation Information
12.20.2 The Colgate-Palmolive Company Description and Business Overview
12.20.3 The Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
12.20.4 The Colgate-Palmolive Company Products Offered
12.20.5 The Colgate-Palmolive Company Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over the Counter (OTC) Drugs & Dietary Supplements Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Segments
Table 2. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesic & pain relievers
Table 5. Major Manufacturers of Dermatological products
Table 6. Major Manufacturers of Cough, cold, and flu products
Table 7. Major Manufacturers of Vitamin supplements
Table 8. Major Manufacturers of Mineral Supplements
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Regions 2015-2020 (K MT)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Regions (2015-2020)
Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Region (2021-2026) (K MT)
Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturers (2015-2020)
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
Table 20. Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Price (2015-2020) (USD/MT)
Table 23. Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 25. Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2015-2020)
Table 31. Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2021-2026)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 35. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2021-2026)
Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) of Key Companies (2015-2020)
Table 40. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Company (2015-2020)
Table 41. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 43. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 44. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Type (2015-2020)
Table 46. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2021-2026)
Table 47. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2021-2026)
Table 48. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2026)
Table 50. Japan Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Type (2021-2026)
Table 51. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 52. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 53. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2021-2026)
Table 55. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2021-2026)
Table 56. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2026)
Table 58. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 59. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 60. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 62. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 63. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 64. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020) (K MT)
Table 67. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Table 70. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 71. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 75. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 78. Pfizer Inc. Corporation Information
Table 79. Pfizer Inc. Description and Business Overview
Table 80. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 82. Pfizer Inc. Recent Development
Table 83. Novartis International AG Corporation Information
Table 84. Novartis International AG Description and Business Overview
Table 85. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Novartis International AG Product
Table 87. Novartis International AG Recent Development
Table 88. Roche Holding AG Corporation Information
Table 89. Roche Holding AG Description and Business Overview
Table 90. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Roche Holding AG Product
Table 92. Roche Holding AG Recent Development
Table 93. Merck & Co., Inc. Corporation Information
Table 94. Merck & Co., Inc. Description and Business Overview
Table 95. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Merck & Co., Inc. Product
Table 97. Merck & Co., Inc. Recent Development
Table 98. Sanofi S.A Corporation Information
Table 99. Sanofi S.A Description and Business Overview
Table 100. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Sanofi S.A Product
Table 102. Sanofi S.A Recent Development
Table 103. Johnson & Johnson Corporation Information
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson Product
Table 107. Johnson & Johnson Recent Development
Table 108. Gilead Sciences Corporation Information
Table 109. Gilead Sciences Description and Business Overview
Table 110. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Gilead Sciences Product
Table 112. Gilead Sciences Recent Development
Table 113. GlaxoSmithKline plc. Corporation Information
Table 114. GlaxoSmithKline plc. Description and Business Overview
Table 115. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. GlaxoSmithKline plc. Product
Table 117. GlaxoSmithKline plc. Recent Development
Table 118. Bayer Healthcare AG Corporation Information
Table 119. Bayer Healthcare AG Description and Business Overview
Table 120. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Bayer Healthcare AG Product
Table 122. Bayer Healthcare AG Recent Development
Table 123. AstraZeneca plc. Corporation Information
Table 124. AstraZeneca plc. Description and Business Overview
Table 125. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. AstraZeneca plc. Product
Table 127. AstraZeneca plc. Recent Development
Table 128. Alacer Corp. Corporation Information
Table 129. Alacer Corp. Description and Business Overview
Table 130. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 131. Alacer Corp. Product
Table 132. Alacer Corp. Recent Development
Table 133. Alcon Inc. Corporation Information
Table 134. Alcon Inc. Description and Business Overview
Table 135. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Alcon Inc. Product
Table 137. Alcon Inc. Recent Development
Table 138. Alfresa Pharma Corporation Corporation Information
Table 139. Alfresa Pharma Corporation Description and Business Overview
Table 140. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 141. Alfresa Pharma Corporation Product
Table 142. Alfresa Pharma Corporation Recent Development
Table 143. Alkalon A/S Corporation Information
Table 144. Alkalon A/S Description and Business Overview
Table 145. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. Alkalon A/S Product
Table 147. Alkalon A/S Recent Development
Table 148. Alliance Healthcare Corporation Information
Table 149. Alliance Healthcare Description and Business Overview
Table 150. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 151. Alliance Healthcare Product
Table 152. Alliance Healthcare Recent Development
Table 153. Allergan, Plc. Corporation Information
Table 154. Allergan, Plc. Description and Business Overview
Table 155. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 156. Allergan, Plc. Product
Table 157. Allergan, Plc. Recent Development
Table 158. Reckitt Benckiser Plc. Corporation Information
Table 159. Reckitt Benckiser Plc. Description and Business Overview
Table 160. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 161. Reckitt Benckiser Plc. Product
Table 162. Reckitt Benckiser Plc. Recent Development
Table 163. Bausch & Lomb Corporation Information
Table 164. Bausch & Lomb Descripti
  • Global Medical Foods for Inborn Errors of Metabolism Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Medical Foods for Inborn Errors of Metabolism market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Foods for Inborn Errors of Metabolism business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growt......
  • Global OX40 Receptor Agonist Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 160
    According to this study, over the next five years the OX40 Receptor Agonist market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in OX40 Receptor Agonist business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of OX40 Receptor Agonist market ......
  • Global NF-KB Inhibitors Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the NF-KB Inhibitors market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in NF-KB Inhibitors business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of NF-KB Inhibitors market by product type......
  • Global and United States Diabetes Treatment Drugs Market Growth (Status and Outlook) 2020-2025
    Published: 30-Oct-2020        Price: US 3960 Onwards        Pages: 103
    This study researches the Diabetes Treatment Drugs market overview in global and United States market. For the global market, this report focuses on the market size of Diabetes Treatment Drugs in global, regional and country-level market, by regions (countries), by Type, and by Application, for the period 2015-2025. It also includes the Diabetes Treatment Drugs provides details and data information by players for the period 2015-2020. For United States market, the r......
  • Global Diabetes Treatment Drugs Market Growth (Status and Outlook) 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 131
    According to this study, over the next five years the Diabetes Treatment Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Diabetes Treatment Drugs business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetes Treatment Drugs market by ......
  • Global Knee Hyaluronic Acid Injection Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 136
    According to this study, over the next five years the Knee Hyaluronic Acid Injection market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Knee Hyaluronic Acid Injection business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Knee Hyalur......
  • Global Medical Nitroglycerin Spray Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Medical Nitroglycerin Spray market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Medical Nitroglycerin Spray business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Nitroglyc......
  • Global Ertapenem API Market Growth 2020-2025
    Published: 30-Oct-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Ertapenem API market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ertapenem API business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem API market by product type, applica......
  • Global and Blockchain in Pharma Supply Chain Market Growth (Status and Outlook) 2020-2025
    Published: 30-Oct-2020        Price: US 3960 Onwards        Pages: 101
    This study researches the Blockchain in Pharma Supply Chain market overview in global and market. For the global market, this report focuses on the market size of Blockchain in Pharma Supply Chain in global, regional and country-level market, by regions (countries), by Type, and by Application, for the period 2015-2025. It also includes the Blockchain in Pharma Supply Chain provides details and data information by players for the period 2015-2020. For market, the re......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs